Table 1.
All cells used in the study
| Types | Cell lines | Source | Culture condition |
|---|---|---|---|
| Gastric cancer | AGS | ATCC | RPMI-1640+10% FBS |
| Lung cancer | PG | Gifted by Dr. Zhang Zhiqian (Peking University) | RPMI-1640+10% FBS |
| A549 | ATCC | RPMI-1640+10% FBS | |
| H1299 | ATCC | RPMI-1640+10% FBS | |
| GLC-82 | ATCC | RPMI-1640+10% FBS | |
| Colon cancer | LoVo | ATCC | RPMI-1640+10% FBS |
| SW620 | ATCC | RPMI-1640+10% FBS | |
| HCT116 | ATCC | RPMI-1640+10% FBS | |
| HT29 | ATCC | RPMI-1640+10% FBS | |
| DLD1 | ATCC | RPMI-1640+10% FBS | |
| SW480 | ATCC | RPMI-1640+10% FBS | |
| MC38 | ATCC | RPMI-1640+10% FBS | |
| Liver cancer | SMMC-7221 | ATCC | RPMI-1640+10% FBS |
| BEL-7402 | ATCC | RPMI-1640+10% FBS | |
| HepG2 | ATCC | DMEM+10% FBS | |
| Bladder cancer | T24 | ATCC | RPMI-1640+10% FBS |
| EJ | ATCC | RPMI-1640+10% FBS | |
| Pancreatic cancer | PANC1 | Provided by Dr. Zhao Xiaohang (Chinese Academy of Medical Sciences and Peking Union Medical College) | DMEM+10% FBS |
| SW1990 | DMEM+10% FBS | ||
| Esophagus cancer | EC9706 | ATCC | RPMI-1640+10% FBS |
| KYSE70 | Gifted by Dr. Liu Zhihua (Chinese Academy of Medical Sciences and Peking Union Medical College) | RPMI-1640+10% FBS | |
| Breast cancer | MCF7 | ATCC | RPMI-1640+10% FBS |
| BICR | ATCC | RPMI-1640+10% FBS | |
| MDA-MB-231 | ATCC | RPMI-1640+10% FBS | |
| 4T1 | ATCC | RPMI-1640+10% FBS | |
| Nasopharyngeal cancer | CNE | Provided by Dr. Wang naijing (Peking University) | RPMI-1640+10% FBS |
| Cervical cancer | HeLa | ATCC | RPMI-1640+10% FBS |
| Blood vessel | HUVEC | Umbilical cord | EGM-2 BulletKit |
| HMEC | ATCC | DMEM+10% FBS | |
| Lymphatic vessel | HDLEC | Gifted by Dr. Xing Rui (Peking University) | DMEM+10% FBS |